Evidence map›Paper›PMID 25323068›Full record

ArticleNature communications2014

'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak.

Kerstin Voelz, Simon A Johnston, Leanne M Smith, Rebecca A Hall, Alexander Idnurm, Robin C May

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Deciphering cargo contents in extracellular vesicles ofComputational and structural biotechnology journal · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Acta biochimica et biophysica Sinica · 2024
    Article
  13. Intracellular Pathogens: Infection, Immunity, and Intervention.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  14. Immune evasion byFrontiers in immunology · 2024
    Article
  15. Review
  16. Review
  17. Extracellular Vesicles fromJournal of fungi (Basel, Switzerland) · 2023
    Article
  18. Review
  19. Article
  20. Gene, virulence and related regulatory mechanisms inActa biochimica et biophysica Sinica · 2022
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kerstin Voelz1] Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, West Midlands, Birmingham B15 2TT, UK [2] National Institute of Health Research Surgical Reconstruction and Microbiology Research Centre, Queen Elizabeth Hospital Birmingham, Birmingham B15 2TH, UK.
Simon A Johnston1] Department of Infection and Immunity, University of Sheffield, Medical School, Beech Hill Road, Sheffield S10 2RX, UK [2] Bateson Centre, Department of Biomedical Sciences, University of Sheffield, Firth Court, Western Bank S10 2TN, UK.
Leanne M SmithInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, West Midlands, Birmingham B15 2TT, UK.
Rebecca A HallInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, West Midlands, Birmingham B15 2TT, UK.
Alexander IdnurmSchool of Biological Sciences, University of Missouri, Kansas City, Missouri 64110, USA.
Robin C May1] Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, West Midlands, Birmingham B15 2TT, UK [2] National Institute of Health Research Surgical Reconstruction and Microbiology Research Centre, Queen Elizabeth Hospital Birmingham, Birmingham B15 2TH, UK.
University of Birmingham · GBQueen Elizabeth Hospital Birmingham · GBUniversity of Missouri–Kansas City · USUniversity of Sheffield · GB

Funding

Antifungal drug target prioritization using Cryptococcus neoformansR21AI094364 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI IDNURM, ALEXANDER · 2012 to 2013
$409k
European Research Council 614562Medical Research Council G0601171Medical Research Council MR/J008176/1Medical Research Council MR/J009156/1NIAID NIH HHS AI094364NIAID NIH HHS R21 AI094364Wellcome Trust 088148Wellcome Trust WT088148MF
6 · The paper itself

Abstract

Cryptococcus gattii is an emerging intracellular pathogen and the cause of the largest primary outbreak of a life-threatening fungal disease in a healthy population. Outbreak strains share a unique mitochondrial gene expression profile and an increased ability to tubularize their mitochondria within host macrophages. However, the underlying mechanism that causes this lineage of C. gattii to be virulent in immunocompetent individuals remains unexplained. Here we show that a subpopulation of intracellular C. gattii adopts a tubular mitochondrial morphology in response to host reactive oxygen species. These fungal cells then facilitate the rapid growth of neighbouring C. gattii cells with non-tubular mitochondria, allowing for effective establishment of the pathogen within a macrophage intracellular niche. Thus, host reactive oxygen species, an essential component of the innate immune response, act as major signalling molecules to trigger a 'division of labour' in the intracellular fungal population, leading to increased pathogenesis within this outbreak lineage.

Indexed as

Oxidative StressRespiratory BurstAnimalsAutophagyCell LineCell ProliferationCryptococcosisCryptococcus gattiiDisease Models, AnimalDisease OutbreaksGenotypeGreen Fluorescent ProteinsImmunity, InnateMacrophagesMiceMitochondriaGreen Fluorescent ProteinsMitogen-Activated Protein KinasesReactive Oxygen Species

Identifiers

PMID25323068
PMCPMC4208095
OpenAlexW2018055448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.